Stakeholder Identification

Key Issues

• Employee benefits and compensation, Labor relations, Occupational health and safety

Significance to HanchorBio

• Employees are the company’s most important assets and growth partners. Beyond building a safe and secure working environment and safeguarding employee rights, HanchorBio enhances talent capital and competitiveness by supporting career development and training programs that improve employee skills.

Communication Channels

• Labor-management meeting

Key Issues

• Clinical trial quality and ethics, Patient safety, Data integrity, Joint R&D progress, Regulatory compliance

Significance to HanchorBio

• Hospitals and clinical trial institutions are indispensable partners in new drug development. Ensuring compliance with international standards (ICH-GCP, TFDA, FDA, etc.), safeguarding patient rights, and maintaining reliable data are essential for advancing R&D, securing drug

Communication Channels

• Regular clinical trial coordination meetings (quarterly or based on trial stage needs)
•  Collaboration agreements and compliance reviews with hospitals and research centers
•  Participation in academic symposia, ethics forums, and international conferences (ad hoc)
•  Project management platforms and designated contact windows for transparent year-round communication

Key Issues 

• Operational and financial performance
•  Employee welfare and compensation
• R&D compliance and clinical trial ethics
•  Drug safety and quality management
•  Data privacy and information security

Significance to HanchorBio

• The company operates in accordance with government regulations and international standards (e.g., GxP, TFDA, FDA, NMPA), guided by the principles of “patient-centricity” and “integrity and compliance.” HanchorBio fulfills its corporate social responsibility by ensuring drug development is safe, effective, ethical, and sustainable.

Communication Channels

•  Meetings with authorities, hospitals, and research institutions to align on clinical and regulatory requirements
• Regulatory forums, industry seminars, professional training, and informal exchanges (ad hoc)
•  Participation in government and industry association panels, workshops, reviews, and evaluations (ad hoc)

Key Issues 

• Occupational health and safety
• Labor relations
• Workplace equality and diversity

Significance to HanchorBio

• Suppliers and contractors are vital to sustaining operations. They are required to comply with HanchorBio’s standards and codes of conduct.

Communication Channels

• Meetings to promote two-way communication (monthly/as needed)

Significance to HanchorBio

• Shareholders and investors provide the capital essential for long-term growth and sustainable operations. They are focused on pipeline progress, clinical outcomes, financial soundness, and growth strategies. HanchorBio is committed to stability and integrity, delivering strong R&D and operational performance to reward shareholders and enhance company value.

Communication Channels

• Investor email ([email protected]) for inquiries and responses
• Investor visits or meetings (domestic and international, as needed)
•  Participation in investor conferences hosted by brokerages and associations (ad hoc)
• Annual shareholder reports and financial statements (with online versions)
• Annual shareholder meetings with case-by-case and electronic voting

Key Issues

• R&D progress and outcomes
•  Clinical trial compliance and patient safety
•  Corporate governance
• Operational and financial performance
• Sustainability and social responsibility

Key Issues

• Sustainability practices
•  Clinical research ethics and patient rights protection

Significance to HanchorBio

• Communities, NGOs, media, and key opinion leaders are important partners in the company’s growth with society. While developing new drugs, HanchorBio also emphasizes social responsibility, actively responding to expectations regarding sustainability, clinical ethics, and environmental commitments. Guided by a philosophy of “patient-centricity and thriving with society,” the company invests in community support and builds mutual trust.

Communication Channels

•  Engagement with local groups through the public affairs team (ad hoc)
•  Press releases, media briefings, and interviews (ad hoc)
• Participation in associations, industry forums, and conferences (regular and ad hoc)

Community Consultation Framework

•  Provide balanced and transparent information to help the community and the public better understand HanchorBio.
• Maintain ongoing dialogue with the community, seeking collaborative solutions to jointly promote local healthcare and medical support.
• Offer channels for expressing opinions, and, where aligned with the company’s development strategy, consider incorporating them into decision-making.
• Disclose company development progress and outcomes in an open and transparent manner.

Key Issues

• Employee welfare and compensation
• Operational and financial performance
• Information and cybersecurity
• Labor relations
• R&D trends
•  Clinical and regulatory developments

Significance to HanchorBio

• Maintaining strong relationships with peers and associations helps HanchorBio track global R&D trends, clinical trial standards, and regulatory developments. Through collaboration, the company leverages shared experience, builds strategic partnerships, and enhances R&D efficiency and global competitiveness.

Communication Channels

• Participation in biotech/pharma associations, regulatory forums, and international conferences (ad hoc)
• Bilateral or multilateral exchanges and visits with biotech/pharma companies (ad hoc)
• Cross-industry or multinational strategy meetings and academic forums (ad hoc)

Key Issues

• R&D innovation and new drug development
•  Preclinical and clinical collaboration
•  Data integrity and research ethics
•  Product safety and quality

Significance to HanchorBio

• Academic researchers and professional institutions are vital resources for driving innovation. Collaborations accelerate development, strengthen scientific credibility, and enhance clinical value. Academic research also shapes industry technology development and directly impacts HanchorBio’s professional reputation and social trust.

Communication Channels

• Weekly R&D progress review meetings
• Participation in lectures, seminars, and academic forums (ad hoc)